期刊文献+

不同前哨淋巴结的定义标准对核素法行乳腺癌前哨淋巴结定位活检的影响 被引量:3

原文传递
导出
摘要   核素法行乳腺癌前哨淋巴结定位活检中,对于前哨淋巴结的判定标准目前大致可分为3类[1].定义一:有最高放射活性计数的淋巴结[2].定义二:任何淋巴结其体外放射活性和背景值之比至少为3:1或与非前哨淋巴结之比至少为10:1,并且最终活检床的放射活性不超过背景值的1.5倍,否则应继续寻找可能存在的前哨淋巴结[3].定义三:所有有放射活性的淋巴结[4].本研究比较三种不同前哨淋巴结定义对乳腺癌前哨淋巴结定位活检所产生的影响,现报告如下.
出处 《中华普通外科杂志》 CSCD 北大核心 2006年第4期300-301,共2页 Chinese Journal of General Surgery
基金 浙江省卫生厅基金资助项目(2002A051)
  • 相关文献

参考文献7

  • 1宋向阳,王林波,吴金民.乳腺癌前哨淋巴结定位活检存在的问题[J].中华普通外科杂志,2005,20(2):135-136. 被引量:2
  • 2De Cicco C,Cremonesi M,Luini A,et al.Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.J Nucl Med 1998,39:2080-2084.
  • 3Bass SS,Lyman GH,McCann CR,et al.Lymphatic mapping and sentinel lymph node biopsy.Breast J,1999,5:288-295.
  • 4Layeeque R,Kepple J,Henry-Tillman RS,et al.Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.Ann Surg,2004,239:841-848.
  • 5Martin RC,Fey J,Yeung H,et al.Highest isotope count does not predict sentinel node positivity in all breast cancer patients.Ann Surg Oncol,2001,8:592-597.
  • 6Wong SL,Edwards M J,Chao C,et al.Sentinel lymph node biopsy for breast cancer:impact of the number of sentinel nodes removed on the false-negative rate.J Am Coll Surg,2001,192:684-689.
  • 7McCarter MD,Yeung H,Fey J,et al.The breast cancer patient with multiple sentinel nodes:when to stop? J Am Coll Surg,2001,192:692-697.

二级参考文献12

  • 1Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of tile sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 1993,2:335-339.
  • 2Donahue EJ. Sentinel node imaging and biopsy in breast cancer patients. Am J Surg, 2001,182:426-428.
  • 3Shimazu K, Tamaki Y, Taguchi T, et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotberapy-treated breast carcinoma. Cancer, 2004, 100: 2555-2561.
  • 4Layeeque R, Kepple J, Henry-Tillnmn RS, et al. Intraoperative subareolar radioisotope injection for immediate sentinel lymph nodebiopsy. Ann Surg, 2004,239:841-848.
  • 5Chagpar A, Matin Ⅲ RC, Chao C, et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy.Arch Surg, 2004, 139:614-620.
  • 6Kollias J, Gill PG, Coventry BJ, et al. Clinical and histological factors associated with sentinel node identification in breast cancer. Aust N Z J Surg, 2000,70:485-489.
  • 7McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg, 2000,231:724-731.
  • 8Johnson N, Soot L, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Am J Surg, 2000, 179:386-388.
  • 9Dupont EL, Salud CJ, Peltz ES, et al. Clinical relevance of interml mammary node mapping as a guide to radiation therapy. Am J Surg,2001,182:321-324.
  • 10Fournier K, Schiller A, Perry RR, et al. Micrometastals in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg, 2004,239:859-865.

共引文献1

同被引文献1

  • 1Cady B.Is axillary lymph node dissection necessary in routine management of breast cancer? No. Important.Adv Oncol, 1997,3(5): 246-260.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部